CLS B — Clinical Laserthermia Systems AB Income Statement
0.000.00%
Last trade - 00:00- SEK60.30m
- SEK34.98m
- SEK18.78m
Annual income statement for Clinical Laserthermia Systems AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.33 | 2.25 | 6.27 | 8.27 | 18.8 |
| Cost of Revenue | |||||
| Gross Profit | -39.3 | -46.3 | -49.1 | -39.8 | -31 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 53.4 | 62.9 | 73.7 | 74.2 | 73 |
| Operating Profit | -52.1 | -60.7 | -67.4 | -65.9 | -54.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -57.9 | -64.1 | -71.3 | -80.9 | -47.9 |
| Net Income After Taxes | -57.9 | -64.1 | -71.3 | -80.9 | -47.9 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -57.9 | -63.6 | -70.7 | -79.8 | -47.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -57.9 | -63.6 | -70.7 | -79.8 | -47.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -64.2 | -56 | -53 | -22.9 | -4.33 |
| Dividends per Share |